Clinical trial · Observational
SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer
Cytogenetic and Flow Cytometric Analysis of : Renal Cell Carcinoma: A Companion Protocol to SWOG-8949
NCT00900042CI-TRIAL-00013875completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: DNA analysis of tumor tissue may help doctors predict how well patients will respond to treatment. PURPOSE: This laboratory study is analyzing the DNA in tumor tissue from patients with metastatic kidney cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Kidney Cancer | Malignant Kidney Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (6)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| chromosomal translocation analysis | Genetic | — | UNRESOLVED |
| cytogenetic analysis | Genetic | — | UNRESOLVED |
| DNA ploidy analysis | Genetic | — | UNRESOLVED |
| DNA stability analysis | Genetic | — | UNRESOLVED |
| flow cytometry | Other | — | UNRESOLVED |
| laboratory biomarker analysis | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (5)
- measure
- Number of successes per number of evaluable samples
- timeFrame
- up to 4 years after registration
- description
- Success is defined as obtaining at least 10 analyzable metaphases.
- measure
- Number of abnormalities per number of successes
- timeFrame
- up to 4 years after registration
- description
- Abnormality is defined as at lease one clonal chromosomal abnormality.
- measure
- Correlation of tumor response to treatment with the type and number of abnormalities
- timeFrame
- up to 4 years after registration
- description
- Abnormality is defined as at lease one clonal chromosomal abnormality.
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
DISEASE CHARACTERISTICS: * Diagnosis of renal cell carcinoma * Any T, any N, M1 disease as specified in SWOG-8949 * Eligible for and registered on the nephrectomy arm\* (arm I) of SWOG-8949 NOTE: \*Patients must be registered on this study before undergoing nephrectomy on SWOG-8949 PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * See Disease Characteristics
References
Publications (0)
Data not yet available
No reference posted for this study.